Llwytho...
Dual epigenetic modifiers for cancer therapy
Epigenetic drug discovery is an emerging strategy for the treatment of cancer and other pathologies. Here, we discuss our recent discovery of first-in-class dual reversible inhibitors of the histone methyltransferase activity of G9a/EHMT2 and DNA methyltransferases showing in vivo efficacy in human...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Mol Cell Oncol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taylor & Francis
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5540207/ https://ncbi.nlm.nih.gov/pubmed/28868353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1342748 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|